Advertisement
Research Article| Volume 152, SUPPLEMENT 1, s43-s48, October 01, 1997

Fasciculations: what do we know of their significance?

      Abstract

      Fasciculations are observed in patients with neurogenic disorders and in healthy individuals. Depending on the associated clinical symptoms and signs, they may signify the presence of a variety of disorders of the lower motor neuron. Divergent and occasionally conflicting opinions prevail regarding the aetiology, pathogenesis, clinical significance, neurophysiological characteristics and the physiological site of origin of fasciculations. In this review we examine the published literature and attempt to clarify these issues.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Association of Electromyography and Electrodiagnosis (AAEE)
        AAEE glossary of terms in clinical electromyography.
        Muscle Nerve. 1987; 10: G1-G44
        • Baker T.
        • Stanec A.
        Drug actions at mammalian motor nerve endings: the suppression of neostigmine-induced fasciculations by vecuronium and isoflurane.
        Anesthesiology. 1987; 67: 942-947
        • Bostock H.
        • Sharief M.
        • Reid M.G.
        • Murray N.M.F.
        Axonal ion channel dysfunction in amyotrophic lateral sclerosis.
        Brain. 1995; 118: 217-225
        • Buchthal F.
        • Houcke P.
        Electromyographical examination of patients suffering from poliomyelitis followed up six months after the acute stage of the disease.
        Acta Med. Scand. 1944; 116: 148-164
        • Collier C.B.
        Suxamethonium fasciculations: a topographical study.
        Anaesth. Intensive Care. 1980; 8: 26-33
        • Conradi S.
        • Grimby L.
        • Lundemo G.
        Pathophysiology of fasciculations in ALS as studied by electromyography of single motor units.
        Muscle Nerve. 1982; 5: 202-208
      1. Carvalho, M., Swash, M., 1997. Fasciculation poentials in amyotrophic lateral sclerosis and other neurogenic disorders: a comparative electrophysiological investigation. Muscle Nerve (in press).

        • De Jong H.
        • Simons D.J.
        A compararive study of fibrillation and tremor.
        J. Am. Med. Assoc. 1942; 118: 702-705
        • Denny-Brown D.
        Interpretation of the electromyogram.
        Arch. Neurol. Psychiatry. 1949; 61: 99-128
        • Denny-Brown D.
        • Pennybacker J.F.
        Fibrillation and fasciculation in voluntary muscle.
        Brain. 1938; 61: 311-334
        • Esteban A.
        • Traba A.
        Fasciculation-myokimic activity and prolonged nerve conduction block. A physiopathological relationship in radiation induced brachial plexopathy.
        Electroencephalogr. Clin. Neurophysiol. 1993; 89: 382-389
        • Forster F.M.
        • Borkowski W.J.
        • Alpers M.J.
        Effects of denervation on fasciculaton in human muscle. Relation of fibrillations to fasciculations.
        Arch. Neurol. Psychiatry. 1946; 56: 276-283
        • Forster F.M.
        • Alpers B.J.
        Site of origin of fasciculations in voluntary muscle.
        Arch. Neurol. Psychiatry. 1944; 51: 264-267
        • Guiloff R.J.
        • Modarres-Sadeghi H.
        Voluntary activation and fibre density of fasciculations in motor neuron disease.
        Ann. Neurol. 1992; 31: 416-424
        • Howard R.S.
        • Murray N.M.F.
        Surface EMG in the recording of fasciculations.
        Muscle Nerve. 1992; 15: 1240-1245
        • Janko M.
        • Trontelj J.V.
        • Gersak K.
        Fasciculations in motor neuron disease: discharge rate reflects extent and recency of collateral sprouting.
        J. Neurol. Neurosurg. Psychiatry. 1989; 52: 1375-1381
        • Langley J.N.
        • Kato T.
        The physiological action of physostigmine and its action on denervated skeletal muscle.
        J. Physiol. (London). 1915; 49: 410-431
        • Masland R.L.
        • Wigton R.S.
        Nerve activity accompanying fasciculation produced by prostigmin.
        J. Neurophysiol. 1940; 3: 269-275
        • Mills K.R.
        Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation.
        Brain. 1995; 118: 971-982
        • Montagna P.
        • Liguori R.
        • Zucconi M.
        • Lugaresi A.
        • Cirignotta F.
        • Lugaresi E.
        Fasciculations during wakefulness and sleep.
        Acta Neurol. Scand. 1987; 76: 152-154
        • Norris Jr., F.H.
        Synchronous fasciculation in motor neuron disease.
        Arch. Neurol. 1965; 13: 495-500
        • Odom G.
        • Russel C.K.
        • McEachern D.
        Studies of neuromuscular disorders: the myogram, blood cholinesterase and the effect of prostigmin in myasthenia gravis and progressive muscular atrophy.
        Brain. 1943; 66: 1-17
        • Olney R.K.
        • Aminoff M.J.
        • So Y.T.
        Clinical and electrodiagnostic features of X-linked recessive bulbo-spinal neuronopathy.
        Neurology. 1991; 41: 825-828
        • Patel A.N.
        • Swami R.K.
        Muscle percussion and neostigmine test in the clinical evaluation of neuromuscular disorders.
        New Engl. J. Med. 1969; 281: 523-526
        • Raines A.
        • Henderson T.R.
        • Dretchen K.L.
        Effects of calcium channel blocking agents on neostigmine-induced fasciculations.
        Eur. J. Pharmacol. 1989; 173: 11-17
        • Randell T.
        • Yli-Hankala A.
        • Lindgren L.
        Isoflurane inhibits muscle fasciculations caused by succinylcholine in children.
        Acta Anaesthesiol. Scand. 1993; 37: 262-264
        • Raudino F.
        Fasciculations in peripheral neuropathies.
        Electromyogr. Clin. Neurophysiol. 1991; 3: 53-54
        • Romano J.G.
        Reduction of fasciculations in patients with ALS with the use of gabapentin.
        Arch. Neurol. 1996; 53: 716
        • Roth G.
        Fasciculations d'origine peripherique.
        Electromyography. 1971; 11: 413-428
        • Roth G.
        The origin of fasciculations.
        Ann. Neurol. 1982; 12: 542-554
        • Roth G.
        Fasciculations and their F-response. Localisation of their axonal origin.
        J. Neurol. Sci. 1984; 63: 299-306
        • Roth G.
        • Rohr J.
        • Majistris M.R.
        • Ochsner F.
        Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokimia. Evolution to tetraplegia.
        Eur. Neurol. 1986; 25: 416-423
        • Russel C.K.
        • Odom G.
        • McEachern D.
        Physiological and chemical studies of neuromuscular disorders.
        Trans. Am. Neurol. Assoc. 1938; 64: 120-124
      2. Russell, W.R., 1952. Poliomyelitis. Edward Arnold, London, p. 84.

        • Sindermann F.
        • Conrad B.
        • Jacobi H.M.
        • Prochazka V.J.
        Unusual properties of repetitive fasciculations.
        EEG Clin. Neurophysiol. 1973; 35: 173-179
      3. Simpson, J.A., Thomaides, T., 1988a. Fasciculation and focal loss of accomodation in peripheral neuropathies. Acta Neurol. Scand. 77 (2), 133–141.

      4. Simpson, J.A., Thomaides, T., 1988b. Local sites of low accommodation of peripheral motor axons and the pathogenesis of fasciculations in amyotrophic lateral sclerosis. Acta Neurol. Scand. 77 (2), 142–147.

        • Sprouse J.S.
        • Baker T.
        • Riker Jr., W.F.
        Pharmacologic exitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine induced fasciculations.
        J. Pharmacol. Exp. Ther. 1985; 235: 864-872
        • Standaert F.G.
        • Riker Jr., W.G.
        The consequences of cholinergic drug actions on motor nerve terminals.
        Ann. NY Acad. Sci. 1967; 144: 517-533
        • Swank R.L.
        • Price J.C.
        Fascicular muscle twitchings in amyotrophic lateral sclerosis. Their origin.
        Arch. Neurol. Psychiatry. 1943; 49: 22-26
        • Trojaborg W.
        • Buchthal F.
        Malignant and benign fasciculations.
        Acta Neurol. Scand. 1965; 41: 251-254
        • Trontelj J.V.
        • Janko M.
        The pathophysiological mechanism of fasciculations in normal people.
        Zdrav Vestn. 1993; 62: 435-439
        • Van der Heijden A.
        • Spaans F.
        • Reulen J.
        Fasciculation potentials in foot and leg muscles of healthy young adults.
        Electroencephalogr. Clin. Neurophysiol. 1994; 93: 163-168
        • Wettstein A.
        The origin of fasciculations in motor neuron disease.
        Ann. Neurol. 1979; 5: 295-300
        • Yli-Hankala A.
        • Randell T.
        • Varpula T.
        • Lindgren L.
        Alfentanil inhibits muscle fasciculations caused by suxamethonium in children and young adults.
        Acta Anaesthesiol. Scand. 1992; 36: 588-591